CAMBRIDGE, MA-Pervasis Therapeutics Inc., which develops medical therapies that integrate biomaterials with cells and drugs, took out a long-term lease on 8,379 sf at One Kendall Square. The agreement gives the firm an amenity-rich location in a class A property close to Harvard University and the Massachusetts Institute of Technology.

“The location is good for them because it has a lot of amenities and parking and it’s in the Kendall Square area so you are rubbing elbows with a lot of life science firms,” Ted Lyon with Trammell Crow Co. in Boston, tells Terms of the lease were not disclosed, but lab space in the Kendall Square area generally ranges from the low $20s to the mid $50s per sf, he says.

Lyon, along with Tom Kent, also with Trammell Crow, represented the tenant, while Tim Bianchi and Matt George, both with Lincoln Property Co. of Boston, represented the owner, One Kendall Square Associates. Pervasis will move from its current offices at 790 Memorial Dr. into the property in early April, joining other biotech names such as Genzyme Corp., Harvard Medical, Identix Pharmaceuticals, Whitehead Institute for BioMedical Research and Charles Stark Draper Laboratories.

The property is part of a nine-building, 668,000-sf mixed use development that is currently being marketed for sale as “a city within a city.” Real estate insiders say the complex, which is more than 70% occupied, could fetch up to $200 million for its owners.

Want to continue reading?
Become a Free ALM Digital Reader.

Once you are an ALM digital member, you’ll receive:

  • Unlimited access to GlobeSt and other free ALM publications
  • Access to 15 years of GlobeSt archives
  • Your choice of GlobeSt digital newsletters and over 70 others from popular sister publications
  • 1 free article* every 30 days across the ALM subscription network
  • Exclusive discounts on ALM events and publications

*May exclude premium content
Already have an account?


© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Dig Deeper



Join GlobeSt

Don't miss crucial news and insights you need to make informed commercial real estate decisions. Join now!

  • Free unlimited access to's trusted and independent team of experts who provide commercial real estate owners, investors, developers, brokers and finance professionals with comprehensive coverage, analysis and best practices necessary to innovate and build business.
  • Exclusive discounts on ALM and GlobeSt events.
  • Access to other award-winning ALM websites including and

Already have an account? Sign In Now
Join GlobeSt

Copyright © 2024 ALM Global, LLC. All Rights Reserved.